To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves

NACompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

January 28, 2014

Primary Completion Date

January 20, 2017

Study Completion Date

September 27, 2018

Conditions
COPDHeterogeneous Emphysema
Interventions
DEVICE

ELVR (Endoscopic Lung Volume Reduction) with Zephyr Valves

Trial Locations (17)

8930

AZ Delta, Menen

9000

Universiteit Gent, Ghent

9700

University Medical Center Groningen, Groningen

13353

Charité Campus Virchow-Klinikum, Berlin

38043

CHU, Grenoble

45239

Ruhrlandklinik Westdeutsches Lungenzentrum, Essen

69126

Thoraxklinik am Universitäts Klinikum Heidelberg, Heidelberg

75013

Groupe Hospitalier Pitié Salpétrière, Paris

75877

Hôpital Bichat Claude Bernard, Paris

06002

CHU Hôpital Pasteur, Nice

221 85

Skane University Hospital, Lund

751 85

Uppsala University Hospital, Uppsala

NG17 4JL

Sherwood Forest Hospitals NHS, Sutton in Ashfield

G81 4DY

West of Scotland Regional Heart & Lung Centre - Golden Jubilee National Hospital, Clydebank

CF144XW

University Hospital of Wales, Cardiff

SW3 6NP

The Royal Brompton Hospital & Harefield NHS Foundation Trust, London

S5 7AU

Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield

All Listed Sponsors
lead

Pulmonx Corporation

INDUSTRY

NCT02022683 - To Improve Lung Function and Symptoms for Emphysema Patients Using Zephyr Valves | Biotech Hunter | Biotech Hunter